Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 23, 2012 - Issue 1
Submit an article Journal homepage
412
Views
11
CrossRef citations to date
0
Altmetric
Corticosteroids in skin diseases

The potency of clobetasol propionate: Serum levels of clobetasol propionate and adrenal function during therapy with 0.05% clobetasol propionate in patients with severe atopic dermatitis

Sara G. A. van VelsenDepartment of Dermatology and Allergology, University Medical Centre Utrecht, Utrecht, The NetherlandsCorrespondence[email protected]
,
Marlise P. De RoosDepartment of Dermatology and Allergology, University Medical Centre Utrecht, Utrecht, The Netherlands
,
Inge M. HaeckDepartment of Dermatology and Allergology, University Medical Centre Utrecht, Utrecht, The Netherlands
,
Rolf W. SparidansDepartment of Pharmaceutical Sciences, Section of Biomedical Analysis, Division of Drug Toxicology, Faculty of Science, Universiteit Utrecht, Utrecht, The Netherlands
&
Carla A. F. M. Bruijnzeel-KoomenDepartment of Dermatology and Allergology, University Medical Centre Utrecht, Utrecht, The Netherlands
Pages 16-20 | Received 20 Sep 2010, Accepted 28 Sep 2010, Published online: 22 Jan 2011

References

  • Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications. Am J Clin Dermatol. 2002;3:141–147.
  • Munro DD. The effect of percutaneously absorbed steroids on hypothalamic–pituitary–adrenal function after intensive use in in-patients. Br J Dermatol. 1976;94(suppl 12):67–76.
  • Gip L, Hamfelt A. Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses. Cutis. 1984;33:215–222.
  • Weston WL, Fennessey PV, Morelli J, Schwab H, Mooney J, Samson C, Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol. 1988;90:532–535.
  • Hehir M, Du VA, Eilon L, Danie MJ, Shenoy EV. Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment. Clin Exp Dermatol. 1983;8:143–151.
  • Antignac JP, Brosseaud A, Gaudin-Hirret I, André F, Bizec BL. Analytical strategies for the direct mass spectrometric analysis of steroid and corticosteroid phase II metabolites. Steroids. 2005;70:205–216.
  • Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh). 1980;92(suppl):44–47.
  • Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: The SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007;157:645–648.
  • Sparidans RW, van Velsen SG, de Roos MP, Schellens JH, Bruijnzeel-Koomen CA, Beijnen JH. Liquid chromatography-tandem mass spectrometric assay or clobetasol propionate in human serum from patients with atopic dermatitis. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:2150–2154.
  • Farmacotherapeutisch Kompas 2009, The Netherlands [accessed December 2009]. Available from: http://www.farmacotherapeutischkompas.nl.
  • Wilson L, Williams DI, Marsh S. Plasma corticosteroid levels in out-patients treated with topical steroids. Br J Dermatol. 1973;88:373–380.
  • Carruthers JA, August PJ, Staughton RC. Observations on the systemic effect of topical clobetasol propionate (Dermovate). Br Med J. 1975;4:203–204.
  • Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–1494.
  • Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol. 2000;25:559–566.
  • Watson AC, Rosenfield RL, Fang VS. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin Endocrinol (Oxf). 1988;28:471–477.
  • Schuetz P, Christ-Crain M, Schild U, Süess E, Facompre M, Baty F, Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 2008;8:1.
  • Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346:321–327.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.